Presentation is loading. Please wait.

Presentation is loading. Please wait.

A. PMPs; B. endotheliocyte-derived MPs; C. leukocyte-derived MPs

Published byHector O’Brien’ Modified over 5 years ago

Similar presentations

Presentation on theme: "A. PMPs; B. endotheliocyte-derived MPs; C. leukocyte-derived MPs"— Presentation transcript:

1 A. PMPs; B. endotheliocyte-derived MPs; C. leukocyte-derived MPs
A. PMPs; B. endotheliocyte-derived MPs; C. leukocyte-derived MPs. *P < 0.05, **P ... A. PMPs; B. endotheliocyte-derived MPs; C. leukocyte-derived MPs. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < The left graph is of unpaired samples compared using unpaired t-tests, and the right graph is of paired samples compared using paired t-tests. AAV: active ANCA-associated vasculitis; DN: diabetic nephropathy; PMPs: platelet-derived microparticles; MPs: microparticles. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Rheumatology (Oxford), kez044, The content of this slide may be subject to copyright: please see the slide notes for details.

2 A. Heat map representation of the protein ...
A. Heat map representation of the protein level analysis showing active (red) and inactive (blue) stage with AAV (P < 0.05, fold change>1.5 or <0.67). B. Volcano-plot showing the distribution of all proteins (grey) in A and significantly different proteins (orange) (P < 0.01, fold change >2). AAV: active ANCA-associated vasculitis. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Rheumatology (Oxford), kez044, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "A. PMPs; B. endotheliocyte-derived MPs; C. leukocyte-derived MPs"

Similar presentations

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Schematic representation of the experimental design.

Figure 1 Schematic representation of the experimental design.
(A) Mean (s.d.) ... (A) Mean (s.d.) baseline values for study variables for patients with and without tophi. (B) Baseline (s.d.) quality of life scores.

(A) Mean (s.d.) ... (A) Mean (s.d.) baseline values for study variables for patients with and without tophi. (B) Baseline (s.d.) quality of life scores.
(A) Calcinosis cutis on the extensor side of the left upper arm ...

(A) Calcinosis cutis on the extensor side of the left upper arm ...
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
Figure 1 Qualitative analysis—themes and subthemes regarding detention minimisation Unless provided in the caption above, the following copyright applies.

Figure 1 Qualitative analysis—themes and subthemes regarding detention minimisation Unless provided in the caption above, the following copyright applies.
(A) mSchober in DESIR; (B) mSchober in SPACE; (C) LSF ...

(A) mSchober in DESIR; (B) mSchober in SPACE; (C) LSF ...
Figure 1 Phases of the research. Author’s own work.

Figure 1 Phases of the research. Author’s own work.
Figure 1. Linkage analyses of the SNPs in the MRE11 gene and haplotype blocks. Haplotype blocks were defined for all ... Figure 1. Linkage analyses of.

Figure 1. Linkage analyses of the SNPs in the MRE11 gene and haplotype blocks. Haplotype blocks were defined for all ... Figure 1. Linkage analyses of.
(A–B) Images of US ... (A–B) Images of US assessment of both patients who developed peripheral arthritis during vedolizumab treatment undergoing US-guided.

(A–B) Images of US ... (A–B) Images of US assessment of both patients who developed peripheral arthritis during vedolizumab treatment undergoing US-guided.
Fig. 1 Bone scintigraphy of the right tibia of the patient at disease onset (A), after 10 years of calcitonin ... Fig. 1 Bone scintigraphy of the right.

Fig. 1 Bone scintigraphy of the right tibia of the patient at disease onset (A), after 10 years of calcitonin ... Fig. 1 Bone scintigraphy of the right.
(A) The heat map shows an overview ...

(A) The heat map shows an overview ...
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
AHA: American Heart Association; ALT: ...

AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.
Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.

Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.

Similar presentations

Ads by Google